How to Verify a Red Light Device’s UK Regulatory Status (MHRA, UKCA)

RedVance manufactures red light therapy panels in Shenzhen and supplies brands selling into the UK, so we deal with UK documentation as part of export. This guide is method: apply it to any supplier’s UK claim. Part of a market-by-market series indexed in our regulatory verification hub.

This is the starting point that catches the most overseas buyers:

A supplier who says “we have UK approval” without specifying which territory has answered a different question. UKCA alone is not sufficient for Northern Ireland, and CE alone may or may not be sufficient for Great Britain depending on transitional arrangements — which have been subject to revision. Confirm the current position for your target territory with a qualified regulatory professional, as rules in this area have changed and may change again.

PARD, the Public Access Registration Database at pard.mhra.gov.uk, is the MHRA’s public record of medical devices registered for the Great Britain market. Before using it, know its limits:

• Searchable by: manufacturer name, or GMDN code name and term.
• Not searchable by: device model number, product name, or serial number. PARD does not contain model-level detail, so a search returning a company name tells you the company is registered — not which specific products are covered.
• What a result confirms: the entity has filed a registration. Nothing about whether the device is safe, effective, approved or endorsed.
• What a result does not confirm: anything about product quality, technical performance, or regulatory review of the device itself.

This is structurally identical to FDA establishment registration in the US — administrative filing, no review — covered in our US guide, and the general pattern across markets in our verification hub.

UKCA and CE for a red light panel can cover either the consumer electrical route or the medical device route — the same distinction as the EU, covered in our EU guide. For most panels sold as wellness products, the marking reflects electrical safety and EMC compliance, not medical device assessment.

For a medical device claim under UKCA, a UK Approved Body may be involved for higher-risk classes, and the assessment process parallels the EU notified body system. For consumer electrical products, the manufacturer self-declares conformity.

What to ask for and read:

• The UK Declaration of Conformity — the legal document behind the marking, listing the applicable UK regulations, the standards applied, and the manufacturer’s details.
• The UK Approved Body details, where one was involved — name and reference number, checkable against the list of approved bodies published by the UK government.
• Whether CE or UKCA is being claimed, and for which territory — because the answer matters for Northern Ireland.
• The underlying test reports — the declaration conclusion, not just the conclusion. Verification method in our certification verification guide.

Non-UK manufacturers placing medical devices on the Great Britain market must appoint a UK Responsible Person (UKRP), who registers the device with the MHRA on the manufacturer’s behalf. Two practical consequences:

• The entity appearing in PARD may be the UKRP, not the factory. This is legitimate and common — it does not mean the manufacturer is absent or unaccountable.
• Ask the supplier: who is the UK Responsible Person for this device? Then confirm the registration is under that entity in PARD.

Entity matching — confirming that the company on the registration, the company on the certificate, and the company you would pay are consistent or consistently explained — is the same discipline as our business registration verification guide.

Most red light panels sold in the UK are not sold as medical devices. A panel marketed as a general wellness or consumer product sits outside UK medical device regulation, and its manufacturer is not required to register with the MHRA as a device manufacturer.

So searching PARD for such a panel and finding nothing is the expected result — not a red flag. Absence from PARD only contradicts a claim when the supplier specifically asserted MHRA registration or medical device status.

What a consumer-route panel does need for the UK is electrical safety, EMC and RoHS conformity — whether through UKCA or under applicable transitional arrangements — and a valid Declaration of Conformity behind the marking. These sit outside PARD and are verified through the documentation, not the database.

1. Established target territory — Great Britain, Northern Ireland, or both.
2. Identified which marking applies to the territory and route: UKCA, CE, or both.
3. UK Declaration of Conformity obtained, reviewed for applicable regulations, standards and manufacturer details.
4. If MHRA medical device registration claimed: searched PARD by manufacturer name, confirmed appearance, understood registration as filing not approval.
5. Identified who the UK Responsible Person is, and confirmed the registration is under that entity.
6. UK Approved Body details obtained where one was involved, and checked against published approved body list.
7. Underlying test reports obtained and reviewed.
8. Model number on the Declaration confirmed against the device being purchased.
9. Current CE transitional acceptance rules confirmed with a regulatory professional — rules in this area have been subject to revision.

Other markets in this series: USA, EU, Australia, Canada, Singapore, Malaysia, Brazil and Mexico. Terms are defined in our glossary.

What a manufacturer can do about it: state plainly which territory is covered, which marking is used and under which route, provide the UK Declaration of Conformity rather than only a CE certificate, name the UK Responsible Person and explain what their role covers, supply the underlying test reports, and avoid presenting MHRA registration as approval — because the MHRA prohibits that in its own database. A supplier who can answer all of this without hesitation is not holding borrowed documentation.